Goodrx Holdings Inc. Stock News

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or GoodRx Holdings, Inc. (GDRX). But which of these two stocks presents investors with t

The consensus price target hints at a 29.1% upside potential for GoodRx Holdings, Inc. (GDRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earn

Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and GoodRx Holdings, Inc. (GDRX). But which of these two stocks is more attractive

GoodRx Holdings, Inc. (GDRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Does GoodRx Holdings, Inc. (GDRX) have what it takes to be a top stock pick for momentum investors? Let's find out.

While the top- and bottom-line numbers for GoodRx Holdings, Inc. (GDRX) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key

GoodRx beat Q4 estimates and announced a new $450 million stock repurchase program. The prescription savings specialist also issued better-than-expected 2024 revenue guidance.

Shares of GoodRx Holdings (GDRX) are jumping Thursday as the company posted its fourth quarter earnings, revealing revenue increased by 7% to $196.6 million. The company also issued full-year guidance

GoodRx Holdings, Inc. (GDRX) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.07 per share a year ago.

GoodRx Holdings, Inc. (GDRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Gene therapy treatments have been making major headlines as advances in gene editing have gone mainstream thanks to the advent of CRISPR/Cas-9 technology. The shot heard around the world in the medic

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading destination for prescription savings in the U.S, today announced it will re

The consensus price target hints at a 27.8% upside potential for GoodRx Holdings, Inc. (GDRX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earn

During flu season, you want to be on top of your strategy on how to quickly get better if you're sick. Each month, PYMNTS tracks the most popular mobile apps in the prescription space for the Provider

GoodRx has a strong value proposition that drives continuous adoption, offering cost savings and price comparisons on medications. The company benefits from a strong network effect, with consumers, PB